U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1597T>C (p.Phe533Leu) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 7, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003478986.1

Allele description [Variation Report for NM_000492.4(CFTR):c.1597T>C (p.Phe533Leu)]

NM_000492.4(CFTR):c.1597T>C (p.Phe533Leu)

Genes:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
LOC111674475:CFTR intron 11 enhancer [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1597T>C (p.Phe533Leu)
HGVS:
  • NC_000007.14:g.117587751T>C
  • NG_016465.4:g.126968T>C
  • NG_056131.3:g.706T>C
  • NM_000492.4:c.1597T>CMANE SELECT
  • NP_000483.3:p.Phe533Leu
  • NP_000483.3:p.Phe533Leu
  • LRG_663t1:c.1597T>C
  • LRG_663:g.126968T>C
  • LRG_663p1:p.Phe533Leu
  • NC_000007.13:g.117227805T>C
  • NM_000492.3:c.1597T>C
Protein change:
F533L
Links:
dbSNP: rs397508238
NCBI 1000 Genomes Browser:
rs397508238
Molecular consequence:
  • NM_000492.4:c.1597T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004223434Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Nov 7, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Cystic fibrosis genetic counseling difficulties due to the identification of novel mutations in the CFTR gene.

Poulou M, Fylaktou I, Fotoulaki M, Kanavakis E, Tzetis M.

J Cyst Fibros. 2012 Jul;11(4):344-8. doi: 10.1016/j.jcf.2012.01.004. Epub 2012 Feb 11.

PubMed [citation]
PMID:
22326559

Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations.

Kambouris M, Banjar H, Moggari I, Nazer H, Al-Hamed M, Meyer BF.

Eur J Pediatr. 2000 May;159(5):303-9.

PubMed [citation]
PMID:
10834512

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004223434.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: CFTR c.1597T>C (p.Phe533Leu) results in a non-conservative amino acid change located in the ABC transporter-like, ATP-binding domain (IPR003439) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 250892 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1597T>C has been reported in the literature in at least one individual affected with Cystic Fibrosis, however the second CFTR variant in this individual remains unknown (e.g., Kambouris_2000). This report therefore does not provide unequivocal conclusions about association of the variant with Cystic Fibrosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 10834512, 22326559). No submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 6, 2024